Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 508,958
  • Shares Outstanding, K 249,489
  • Annual Sales, $ 1,770 K
  • Annual Income, $ -303,660 K
  • 60-Month Beta 1.01
  • Price/Sales 271.28
  • Price/Cash Flow N/A
  • Price/Book 1.80
Trade INO with:

Options Overview Details

View History
  • Implied Volatility 165.22% ( +39.58%)
  • Historical Volatility 70.72%
  • IV Percentile 69%
  • IV Rank 23.58%
  • IV High 571.55% on 07/06/22
  • IV Low 39.88% on 10/10/22
  • Put/Call Vol Ratio 0.13
  • Today's Volume 548
  • Volume Avg (30-Day) 2,173
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 84,736
  • Open Int (30-Day) 88,478

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.14
  • Low Estimate -0.18
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +68.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.88 +1.59%
on 11/30/22
2.61 -26.63%
on 11/15/22
-0.20 (-9.67%)
since 11/01/22
3-Month
1.50 +27.67%
on 10/11/22
2.61 -26.63%
on 11/15/22
-0.41 (-17.81%)
since 09/01/22
52-Week
1.38 +38.77%
on 06/16/22
7.10 -73.03%
on 12/02/21
-4.68 (-70.98%)
since 12/01/21

Most Recent Stories

More News
INOVIO Provides an Update on Lassa Fever and MERS Programs

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious...

INO : 1.92 (-6.13%)
3 Stocks to Avoid Right Now

Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

BIIB : 300.38 (-1.57%)
INO : 1.92 (-6.13%)
OCGN : 1.5050 (-3.53%)
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

NVAX : 16.96 (+2.85%)
PFE : 51.04 (+1.82%)
BNTX : 168.65 (+0.98%)
MRNA : 180.17 (+2.42%)
INO : 1.92 (-6.13%)
BIXT : 0.4100 (-2.40%)
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript

INO earnings call for the period ending September 30, 2022.

INO : 1.92 (-6.13%)
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of 48.28% and 3,880%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

INO : 1.92 (-6.13%)
VBIV : 0.5120 (-1.54%)
Inovio: Q3 Earnings Snapshot

Inovio: Q3 Earnings Snapshot

INO : 1.92 (-6.13%)
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious...

INO : 1.92 (-6.13%)
Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates

Eiger BioPharma (EIGR) delivered earnings and revenue surprises of -12.73% and 2.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EIGR : 4.49 (-1.10%)
INO : 1.92 (-6.13%)
Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today

The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.

MRNA : 180.17 (+2.42%)
BNTX : 168.65 (+0.98%)
PFE : 51.04 (+1.82%)
INO : 1.92 (-6.13%)
INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious...

INO : 1.92 (-6.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 2.26
2nd Resistance Point 2.16
1st Resistance Point 2.10
Last Price 1.92
1st Support Level 1.93
2nd Support Level 1.83
3rd Support Level 1.77

See More

52-Week High 7.10
Fibonacci 61.8% 4.91
Fibonacci 50% 4.24
Fibonacci 38.2% 3.57
Last Price 1.92
52-Week Low 1.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar